Canada markets closed

Panacea Biotec Limited (PANACEABIO.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
132.70-0.40 (-0.30%)
At close: 03:29PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 8.12B
Enterprise Value 6.48B
Trailing P/E 0.61
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.48
Price/Book (mrq)0.96
Enterprise Value/Revenue 1.01
Enterprise Value/EBITDA 0.28

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 312.13%
S&P500 52-Week Change 326.27%
52 Week High 3202.50
52 Week Low 3114.20
50-Day Moving Average 3138.68
200-Day Moving Average 3153.08

Share Statistics

Avg Vol (3 month) 3176.34k
Avg Vol (10 day) 365.11k
Shares Outstanding 561.25M
Implied Shares Outstanding 661.34M
Float 814.95M
% Held by Insiders 173.76%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 19, 2011
Last Split Factor 210:1
Last Split Date 3Feb 03, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -2.12%
Operating Margin (ttm)-2.38%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)5.52B
Revenue Per Share (ttm)51.72
Quarterly Revenue Growth (yoy)30.60%
Gross Profit (ttm)N/A
EBITDA -88.85M
Net Income Avi to Common (ttm)-116.77M
Diluted EPS (ttm)-1.99
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.82B
Total Cash Per Share (mrq)30.57
Total Debt (mrq)206.8M
Total Debt/Equity (mrq)2.45%
Current Ratio (mrq)N/A
Book Value Per Share (mrq)137.93

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A